PubRank

L Perbellini

Author PubWeight™ 56.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hydrocarbon exposure and Parkinson's disease. Neurology 2000 1.70
2 Partition coefficients of some industrial aliphatic hydrocarbons (C5-C7) in blood and human tissues. Br J Ind Med 1985 1.32
3 Solvent exposure in a shoe upper factory. Int Arch Occup Environ Health 1978 1.16
4 Urinary excretion of the metabolites of n-hexane and its isomers during occupational exposure. Br J Ind Med 1981 1.15
5 Urinary excretion of n-hexane metabolites in rats and humans. Int Arch Occup Environ Health 1979 1.10
6 Toluene concentrations in the blood and alveolar air of workers during the workshift and the morning after. Br J Ind Med 1986 1.03
7 Biomonitoring of industrial solvent exposures in workers' alveolar air. Int Arch Occup Environ Health 1980 1.02
8 Methyl ethyl ketone exposure in industrial workers. Uptake and kinetics. Int Arch Occup Environ Health 1984 0.99
9 Reference values for blood benzene in the occupationally unexposed general population. Int Arch Occup Environ Health 1992 0.99
10 Alveolar air and blood dichloromethane concentration in shoe sole factory workers. Int Arch Occup Environ Health 1977 0.99
11 Identification of the metabolites of n-hexane, cyclohexane, and their isomers in men's urine. Toxicol Appl Pharmacol 1980 0.97
12 Benzene in the blood and breath of normal people and occupationally exposed workers. Am J Ind Med 1989 0.97
13 Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Commun Mass Spectrom 1998 0.97
14 Urinary excretion of n-hexane metabolites. A comparative study in rat, rabbit and monkey. Arch Toxicol 1982 0.95
15 Solvent exposure in a shoe upper factory. II. Methylcyclopentane, 2-methylpentane, and 3-methylpentane concentration in alveolar and in environmental air and in blood. Int Arch Occup Environ Health 1979 0.94
16 Lung uptake and metabolism of cyclohexane in shoe factory workers. Int Arch Occup Environ Health 1980 0.94
17 [2,5-hexanedione in biological monitoring of occupational exposure to n-hexane]. Med Lav 1985 0.93
18 Experimental neurotoxicity and urinary metabolites of the C5-C7 aliphatic hydrocarbons used as glue solvents in shoe manufacture. Clin Toxicol 1981 0.92
19 The Gene-Environment Interactions in Respiratory Diseases (GEIRD) Project. Int Arch Allergy Immunol 2010 0.92
20 The validity of urinary metabolites as indicators of low exposures to toluene. Int Arch Occup Environ Health 1985 0.90
21 Biomonitoring of occupational toluene exposure. Int Arch Occup Environ Health 1982 0.90
22 Measurement of the urinary metabolites of N-hexane, cyclohexane and their isomers by gas chromatography. Int Arch Occup Environ Health 1981 0.90
23 Physiologicomathematical model for studying human exposure to organic solvents: kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine. Br J Ind Med 1986 0.88
24 [Sudden death caused by freon 22?]. Med Lav 1993 0.88
25 Benzene in blood as a biomarker of low level occupational exposure. Sci Total Environ 1999 0.86
26 Breath and blood levels of benzene, toluene, cumene and styrene in non-occupational exposure. Int Arch Occup Environ Health 1989 0.86
27 [Gas chromatographic determination of 2,5-hexanedione in the urine]. Med Lav 1987 0.86
28 Biological monitoring of workers exposed to N-N-dimethylformamide. II. Dimethylformamide and its metabolites in urine of exposed workers. Int Arch Occup Environ Health 1995 0.85
29 Alveolar air and blood toluene concentration in rotogravure workers. Int Arch Occup Environ Health 1976 0.85
30 Ethylene oxide exposure. Biological monitoring by analysis of alveolar air and blood. Int Arch Occup Environ Health 1986 0.85
31 Metabolic interaction between n-hexane and toluene in vivo and in vitro. Int Arch Occup Environ Health 1982 0.85
32 Decline of blood and alveolar toluene concentration following two accidental human poisonings. Int Arch Occup Environ Health 1983 0.84
33 Poor metabolization of n-hexane in Parkinson's disease. J Neurol 2003 0.83
34 Benzene in environmental air and human blood. Int Arch Occup Environ Health 1998 0.83
35 Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry. Rapid Commun Mass Spectrom 1998 0.83
36 Hippuric acid and ortho-cresol as biological indicators of occupational exposure to toluene. Am J Ind Med 1987 0.82
37 Nitrous oxide in blood and urine of operating theatre personnel and the general population. Int Arch Occup Environ Health 1995 0.82
38 Blood toluene as a biological index of environmental toluene exposure in the "normal" population and in occupationally exposed workers immediately after exposure and 16 hours later. Int Arch Occup Environ Health 1995 0.82
39 Blood styrene concentrations in a "normal" population and in exposed workers 16 hours after the end of the workshift. Int Arch Occup Environ Health 1993 0.82
40 Is hymenoptera venom allergy an occupational disease? Occup Environ Med 2008 0.81
41 Clinical and pathological features in hydrocarbon-induced parkinsonism. Ann Neurol 1996 0.81
42 Neurotoxic metabolites of "commercial hexane" in the urine of shoe factory workers. Clin Toxicol 1981 0.81
43 Blood and urine concentrations of chemical pollutants in the general population. Med Lav 1995 0.81
44 Biological monitoring of styrene exposure and possible interference of acetone co-exposure. Int Arch Occup Environ Health 1997 0.81
45 [Environmental exposure and blood levels of benzene in gas station attendants. Comparison with the general population]. Med Lav 1997 0.80
46 Biological monitoring in occupational exposure to low levels of 1,3-butadiene. Toxicol Lett 2004 0.80
47 [Peripheral neuropathy caused by incongruous posture in shoe manufacture workers]. Med Lav 1989 0.80
48 Identification of the n-heptane metabolites in rat and human urine. Arch Toxicol 1986 0.79
49 Reference values for blood toluene in the occupationally nonexposed general population. Int Arch Occup Environ Health 1993 0.79
50 Concentration of ethylene oxide in the alveolar air of occupationally exposed workers. Am J Ind Med 1985 0.79
51 Use of computerized digital thermometry for diagnosis of Raynaud's phenomenon. Angiology 1989 0.78
52 n-Hexane-induced parkinsonism: pathogenetic hypotheses. Mov Disord 1995 0.78
53 N-N-dimethylformamide concentration in environmental and alveolar air in an artificial leather factory. Br J Ind Med 1980 0.78
54 Exposure to mutagenic airborne particulate in a rubber manufacturing plant. Mutat Res 1999 0.78
55 Biological monitoring of occupational exposure to n-hexane by measurement of urinary 2,5-hexanedione. Int Arch Occup Environ Health 1993 0.78
56 [Coma caused by probably accidental ingestion of xylene: treatment with hemoperfusion using activated charcoal]. Med Lav 1985 0.78
57 Determination of urinary 2,5-hexanedione in the general Italian population. Int Arch Occup Environ Health 1998 0.78
58 Xenobiotic action on steroid hormone synthesis and sulfonation the example of lead and polychlorinated biphenyls. Int Arch Occup Environ Health 2008 0.77
59 [Effects of cigarette smoking on blood and alveolar air levels of benzene]. Med Lav 1991 0.77
60 Acetone-induced changes in the toxicokinetics of 2,5-hexanedione in rabbits. Scand J Work Environ Health 1986 0.77
61 An experimental study on the neurotoxicity of n-hexane metabolites: hexanol-1 and hexanol-2. Toxicol Appl Pharmacol 1978 0.77
62 Isopropanol exposure: environmental and biological monitoring in a printing works. Br J Ind Med 1983 0.77
63 [Computerized thermometry and skin esthesiometry of the hands in the diagnosis of peripheral vascular disease due to vibrating tools]. Med Lav 1985 0.77
64 Occupational exposure to solvents: field comparison of active and passive samplers and biological monitoring of exposed workers. Ann Occup Hyg 1986 0.76
65 [Occupational exposure to technical hexane: a study of its biotransformation products detectable in the urine]. Ann Ist Super Sanita 1981 0.76
66 Omalizumab in persistent severe bakers' asthma. Allergy 2008 0.76
67 Monitoring of industrial exposure to dimethylformamide by analysis of alveolar air. G Ital Med Lav 1985 0.75
68 [Pollution by solvents and assembly line jobs in shoe and shoe upper factories (author's transl)]. Med Lav 1981 0.75
69 Effects of acute n-hexane and 2,5-hexanedione treatment on the striatal dopaminergic system in mice. J Neural Transm Suppl 1995 0.75
70 [Environmental pollution by the solvents in shoe factories]. Ann Ist Super Sanita 1981 0.75
71 [Alveolar air in the monitoring of occupational exposure to volatile chemical compounds]. Med Lav 1983 0.75
72 Environmental and biological monitoring of occupational methylethyl ketone exposure. Dev Toxicol Environ Sci 1983 0.75
73 [Prevalence of occupational allergic symptoms among bakers of Verona]. G Ital Med Lav Ergon 2008 0.75
74 [Alveolar air as an index of exposure to solvents]. Ann Ist Super Sanita 1981 0.75
75 [Experimental study of the neurotoxicity of cyclohexanol and cyclohexanone]. Med Lav 1981 0.75
76 Toluene coma and liver function. Scand J Work Environ Health 1985 0.75
77 [Chrono-thermometry in the diagnosis of Raynaud-like vasculopathies caused by prolonged use of vibrating tools]. Med Lav 1999 0.75
78 [The combined use of capillaroscopy and skin thermometry in health surveillance of workers exposed to hand-arm vibration]. G Ital Med Lav Ergon 2011 0.75
79 Efficacy of ketanserin in the therapy of Raynaud's phenomenon: thermometric data. Angiology 1991 0.75
80 [New biomarkers of exposure]. G Ital Med Lav Ergon 2004 0.75
81 Biological monitoring of workers exposed to N, N-dimethylfomamide. I. Methods of analysis. Int Arch Occup Environ Health 1995 0.75
82 Interethnic differences at the thermometric response to cold test: functional disorders of blood circulation in hand fingers and exposure to hand-arm vibration. Int Arch Occup Environ Health 2007 0.75
83 Occupational styrene exposure: environmental and biological monitoring. Am J Ind Med 1983 0.75
84 [Follow up of person-related bullying and work-related bullying: evaluation of effectiveness of interventions]. G Ital Med Lav Ergon 2008 0.75
85 [The biological levels of chloroform in the general population]. Med Lav 1992 0.75
86 [Blood interface in environmental and occupational exposure to industrial chemical pollutants]. G Ital Med Lav 1996 0.75
87 [Work-related stress and psychological distress assessment in urban and suburban public transportation companies]. G Ital Med Lav Ergon 2013 0.75
88 Blood acetone concentration in "normal people" and in exposed workers 16 h after the end of the workshift. Int Arch Occup Environ Health 1994 0.75
89 Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon. Angiology 1989 0.75
90 [Guidelines for assessment and management of risks caused by benzene for workers at gas stations]. G Ital Med Lav Ergon 2001 0.75
91 [Update on the neurotoxicity of n-hexane]. Med Lav 1981 0.75
92 [Proposal for a new method of thermal desorption of solvents from passive personal samplers]. G Ital Med Lav 1983 0.75
93 [Disseminated intravascular coagulation (DIC) caused by 1,2-dichloropropane (commercial trielin). Description of 2 cases]. Med Lav 1986 0.75
94 [Vestibular changes in workers in the shoe manufacturing industry]. Med Lav 1979 0.75
95 [Proposal for threshold limit values for organic solvent concentrations in alveolar air]. Ann Ist Super Sanita 1978 0.75
96 [Occupational risk by the pine processionary moth Thaumetopoea pityocampa in the forestry workers of Verona]. G Ital Med Lav Ergon 2013 0.75
97 [Risk assessment concerning hospital personnel participating in the preparation and administration of antineoplastic drugs]. G Ital Med Lav Ergon 2000 0.75
98 [Neuro-arteriopathy probably caused by exposure to nickel and chromium (author's transl)]. Med Lav 1980 0.75
99 [The determination of urinary cyclophosphamide at low concentration levels by liquid-liquid extraction and HPLC/MS/MS analysis]. G Ital Med Lav Ergon 1999 0.75
100 [Reference values of solvents and metabolites in biological samples]. G Ital Med Lav Ergon 2003 0.75
101 [Art. 40 d.lgs 81/80, relations of the competent physician with the National Health Service for a new model of health prevention at work: first results of the analysis of the data of the 3B addendum]. Med Lav 2010 0.75
102 [Evaluation of the metal pollution from welding work]. Ann Ist Super Sanita 1981 0.75
103 [Determination of industrially used solvents in blood, alveolar air and urine in a group of blood donors]. Med Lav 1989 0.75
104 Purge and Trap analysis of toluene in blood: comparison with the Head Space method. Am Ind Hyg Assoc J 1982 0.75
105 [Evidence Based Occupational Medicine: ten year experience with audiometric examination in a handicraft company]. G Ital Med Lav Ergon 2008 0.75
106 [Occupational arsine poisoning: description of a case]. Med Lav 1990 0.75
107 Monitoring of occupational exposure to low concentration of carbon tetrachloride. Dev Toxicol Environ Sci 1983 0.75
108 Biological monitoring of occupational exposure to cyclohexane by urinary 1,2- and 1,4-cyclohexanediol determination. Int Arch Occup Environ Health 1999 0.75